Sandoz (Generics)
Sandoz, the generic pharmaceuticals division of Novartis, is a global industry leader, offering affordable, high-quality medicines to everyone, everywhere. It is the second-largest division of Novartis.
2008 net sales - USD 7.6 billion
Sandoz develops and produces more than 950 compounds, as well as active substances and intermediates. Our operations span five continents and we market products in 130 countries.
In addition to its retail generics business, Sandoz also operates two businesses that focus specifically on anti-infectives and biopharmaceuticals.
Key marketed products (retail generics):
| Product | Originator* | Drug Description |
|---|---|---|
| Omeprazole | Prilosec® | Ulcer and heartburn treatment |
| Amoxicillin / clavulanic acid | Augmentin® | Anti-infective |
| Metoprolol | Lopressor | Antihypertensive |
| Fentanyl | Duragesic® | Analgesic |
| Amlodipine / Benazepril | Lotrel | Antihypertensive |
| Simvastatin | Zocor® | Cholesterol-lowering treatment |
| Acetylsteine | Fluimucil® | Respiratory disease therapy |
| Ketoprofen | Orudis® | Analgesic |
| Azithromycin | Zithromax® | Anti-infective |
| Amoxicillin | Amoxil® | Anti-infective |
*Product names identified by a “®” are trademarks that are not owned by or licensed to the Novartis Group of companies.
Company history
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz.